VIR
Companies
NASDAQ
Vir Biotechnology Inc.
Health Care
$5.21
-$2.14 (-29.16%)
Price Chart
Overview
About VIR
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Market Cap
$1.5B
Volume
9.1M
Avg. Volume
6.8M
P/E Ratio
-1.2647059
Dividend Yield
0.00%
Employees
574.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.91
Moderate Correlation
Volatility
High (0.96)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VIR shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.5B
Volume9.1M
P/E Ratio-1.26
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025